Ads
related to: moderna stock forecast 2030
Search results
A Big Test Is Looming for Pfizer, Moderna, and Novavax
Motley Fool· 12 months agoPfizer (NYSE: PFE), Moderna (NASDAQ: MRNA), and Novavax (NASDAQ: NVAX) were all popular stocks to...
3 Magnificent Growth Stocks to Buy in March
Motley Fool via Yahoo Finance· 4 months agoYou can find growth stocks in every sector. With healthcare making up nearly one-fifth of the U.S. economy, it's a great place to look. Three Motley Fool...
Moderna, Inc.'s (NASDAQ:MRNA) Intrinsic Value Is Potentially 92% Above Its Share Price
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights The projected fair value for Moderna is US$151 based on 2 Stage Free Cash Flow to...
An Intrinsic Calculation For Moderna, Inc. (NASDAQ:MRNA) Suggests It's 46% Undervalued
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights The projected fair value for Moderna is US$241 based on 2 Stage Free Cash Flow to...
2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
Motley Fool· 2 years agoBiotech stocks are like Wall Street's roulette wheel. While many pre-clinical and clinical-stage...
My Top-5 AI Growth Stocks to Buy Hand Over Fist for 2024
Motley Fool via Yahoo Finance· 5 months agoThe S&P 500 recently reached a new record high, signaling a bull market is here, and that means it's...
Is Moderna Setting Expectations Too High?
Motley Fool· 1 year agoModerna (NASDAQ: MRNA) is going to see its revenue nosedive this year, as demand for its COVID vaccine won't be nearly as strong as it was in the past...
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
Investor's Business Daily· 2 years agoThe stock market rally came under pressure, with the Nasdaq breaking below its 50-day line and the...
3 No-Brainer Growth Stocks to Buy in 2023
Motley Fool· 1 year agoIn last-year's difficult market, growth stocks were among the first to suffer. Why should we be confident about growth stocks? Moderna (NASDAQ: MRNA)...
2 Red Flags That Could Sink Pfizer in 2024
Motley Fool via Yahoo Finance· 5 months agoLast year wasn't a particularly good one for Pfizer (NYSE: PFE). Even CEO Albert Bourla says so. "We missed our internal projections and also, we missed...